Literature DB >> 20203

Stabilization of amorphous calcium phosphate by Mg and ATP.

N C Blumenthal, F Betts, A S Posner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20203     DOI: 10.1007/BF02012793

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


× No keyword cloud information.
  7 in total

1.  Transphosphorylation from nucleoside Di- and triphosphates by apatite crystals.

Authors:  S M KRANE; M J GLIMCHER
Journal:  J Biol Chem       Date:  1962-09       Impact factor: 5.157

2.  Atomic structure of intracellular amorphous calcium phosphate deposits.

Authors:  F Betts; N C Blumenthal; A S Posner; G L Becker; A L Lehninger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

3.  Inhibition of apatite formation by phosphorylated metabolites and macromolecules.

Authors:  J D Termine; K M Conn
Journal:  Calcif Tissue Res       Date:  1976-12-22

Review 4.  Mitochondria and calcium ion transport.

Authors:  A L Lehninger
Journal:  Biochem J       Date:  1970-09       Impact factor: 3.857

5.  Complexes in calcium phosphate solutions.

Authors:  A Chughtai; R Marshall; G H Nancollas
Journal:  J Phys Chem       Date:  1968-01

6.  Intermediate states in the precipitation of hydroxyapatite.

Authors:  E D Eanes; I H Gillessen; A S Posner
Journal:  Nature       Date:  1965-10-23       Impact factor: 49.962

7.  Calcium phosphate granules in the hepatopancreas of the blue crab Callinectes sapidus.

Authors:  G L Becker; C H Chen; J W Greenawalt; A L Lehninger
Journal:  J Cell Biol       Date:  1974-05       Impact factor: 10.539

  7 in total
  33 in total

1.  Effect of proteoglycans on in vitro hydroxyapatite formation.

Authors:  N C Blumenthal; A S Posner; L D Silverman; L C Rosenberg
Journal:  Calcif Tissue Int       Date:  1979-03-13       Impact factor: 4.333

2.  Effect of gallium on the in vitro formation, growth, and solubility of hydroxyapatite.

Authors:  N C Blumenthal; V Cosma; S Levine
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

3.  Biomimetic transformations of amorphous calcium phosphate: kinetic and thermodynamic studies.

Authors:  D Rabadjieva; R Gergulova; R Titorenkova; S Tepavitcharova; E Dyulgerova; Chr Balarew; O Petrov
Journal:  J Mater Sci Mater Med       Date:  2010-06-09       Impact factor: 3.896

4.  Dietary magnesium intake and fracture risk: data from a large prospective study.

Authors:  Nicola Veronese; Brendon Stubbs; Marco Solmi; Marianna Noale; Alberto Vaona; Jacopo Demurtas; Stefania Maggi
Journal:  Br J Nutr       Date:  2017-06-20       Impact factor: 3.718

Review 5.  Calcium orthophosphates: crystallization and dissolution.

Authors:  Lijun Wang; George H Nancollas
Journal:  Chem Rev       Date:  2008-09-25       Impact factor: 60.622

6.  Phosphate and calcium uptake by mitochondria and by perfused rat liver induced by the synergistic action of glucagon and vasopressin.

Authors:  F L Bygrave; L Lenton; J G Altin; B A Setchell; A Karjalainen
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

7.  Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

8.  Localization of calcium and phosphorus in early predentin-matrix components by electron spectroscopic imaging (ESI)-analysis in rat molars.

Authors:  D Blottner; H J Wagner
Journal:  Cell Tissue Res       Date:  1989-03       Impact factor: 5.249

9.  Magnesium-aspartate-based crystallization switch inspired from shell molt of crustacean.

Authors:  Jinhui Tao; Dongming Zhou; Zhisen Zhang; Xurong Xu; Ruikang Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

10.  Structure--activity relationship of inhibitors of hydroxyapatite formation.

Authors:  G Williams; J D Sallis
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.